These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12219731)

  • 21. Infliximab in fistulizing Crohn's disease.
    Osterman MT; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
    Wittig BM; Zeitz M
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
    [No Abstract]   [Full Text] [Related]  

  • 24. The Dutch guidelines for treatment with infliximab for Crohn's disease.
    Vermeire S
    Neth J Med; 2006; 64(7):210-1. PubMed ID: 16929081
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammatory bowel disease: anti-TNF strategies and beyond].
    Hoffmann JC
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S76-8. PubMed ID: 15368175
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remicade approved for children with Crohn's disease.
    FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
    [No Abstract]   [Full Text] [Related]  

  • 29. Practical application of anti-TNF therapy for luminal Crohn's disease.
    Kamm MA; Ng SC; De Cruz P; Allen P; Hanauer SB
    Inflamm Bowel Dis; 2011 Nov; 17(11):2366-91. PubMed ID: 21337669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
    Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
    [No Abstract]   [Full Text] [Related]  

  • 31. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
    Joosten AA; van Olffen GH; Hageman G
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1470-2. PubMed ID: 12908351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-alpha antibody.
    Kohara MM; Blum RN
    Clin Infect Dis; 2006 Mar; 42(5):733-4. PubMed ID: 16447129
    [No Abstract]   [Full Text] [Related]  

  • 33. [Infliximab in Crohn disease].
    Taéron C
    Rev Infirm; 2005 Jun; (112):35-6. PubMed ID: 16104480
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
    Sorrentino D; Terrosu G; Vadalà S; Avellini C
    Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 36. Interest heats up in gastrointestinal space.
    Sheridan C
    Nat Biotechnol; 2006 Jul; 24(7):727-8. PubMed ID: 16841039
    [No Abstract]   [Full Text] [Related]  

  • 37. Improving access for anti-tumour necrosis factor-a therapy in inflammatory bowel disease.
    Biehl NA; Pawlik J; Forbes GM
    Med J Aust; 2010 Nov; 193(9):556-7. PubMed ID: 21034395
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of Crohn disease--with special reference to anti-TNF antibody therapy].
    Takazoe M
    Nihon Naika Gakkai Zasshi; 2001 Dec; 90(12):2494-502. PubMed ID: 11917871
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity of anti-TNF antibodies. Has the veil been lifted?
    Van Assche G
    Gut; 2011 Mar; 60(3):285-6. PubMed ID: 21193441
    [No Abstract]   [Full Text] [Related]  

  • 40. European evidence-based consensus on the diagnosis and management of Crohn's disease.
    Hanauer SB; Sandborn WJ
    Gut; 2007 Feb; 56(2):161-3. PubMed ID: 17303600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.